0001517022-24-000015.txt : 20240201 0001517022-24-000015.hdr.sgml : 20240201 20240201164003 ACCESSION NUMBER: 0001517022-24-000015 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240201 DATE AS OF CHANGE: 20240201 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Akebia Therapeutics, Inc. CENTRAL INDEX KEY: 0001517022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 208756903 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36352 FILM NUMBER: 24587531 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-2098 MAIL ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Burke Steven Keith CENTRAL INDEX KEY: 0001619834 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 82 WILLIS ROAD CITY: SUDBURY STATE: MA ZIP: 01776 144 1 primary_doc.xml 144 0001619834 XXXXXXXX LIVE 0001517022 Akebia Therapeutics, Inc. 001-36352 245 First Street Cambridge MA 02142 617-871-2098 Burke Steven Keith Officer Common Stock Morgan Stanley Smith Barney LLC

1 New York Plaza, 38th Floor New York NY 10004

24311 40767.12 198874689 02/01/2024 Nasdaq Common Stock 01/31/2024 Restricted Stock Akebia Therapeutics N 24311 02/01/2024 n/a Y 02/01/2024 Carolyn Rucci